WEED, Inc. (BUDZ)
$0.1
+0.01 (+11.11%)
Rating:
Recommendation:
-
| Symbol | BUDZ |
|---|---|
| Price | $0.1 |
| Beta | 1.626 |
| Volume Avg. | 0.04M |
| Market Cap | 12.348M |
| Shares () | - |
| 52 Week Range | 0.07-0.3 |
| 1y Target Est | - |
| DCF Unlevered | BUDZ DCF -> | |
|---|---|---|
| DCF Levered | BUDZ LDCF -> | |
| ROE | -142.02% | Strong Sell |
| ROA | -46.70% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 145.29% | Buy |
| P/E | - | |
| P/B | 12.34 | Strong Buy |
About
Download (Excel)Mr. Glenn E. Martin
Healthcare
Drug Manufacturers—Specialty & Generic
Other OTC
WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015. WEED, Inc. was incorporated in 1999 and is headquartered in Tucson, Arizona.